Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Hand-Held Biosensor Device Could Enable Immediate, Sensitive Point-of-Care Detection of SARS-CoV-2 from Saliva

By LabMedica International staff writers
Posted on 02 Feb 2021
A handheld biosensor that instantaneously detects viruses and disease in saliva could revolutionize point-of-care (POC) COVID-19 testing.

Blink Science, Inc. More...
(Jacksonville, FL, USA) will soon bring to market, blinkTEST, a handheld biosensor device that can immediately detect COVID-19, and other disease biomarkers in saliva. Most POC testing devices currently available, or that have received Emergency Use Authorization (EUA), provide tests in well over 20-30 minutes. Blink is developing a low-cost, high-tech device that will provide an immediate testing response. The system will provide health reports that can be analyzed immediately to ensure rapid and precise diagnosis for acute and chronic conditions that impact people worldwide. blinkTEST will give instantaneous results without requiring costly genetic testing.

The blinkTEST biosensor reads the electrical charges between antibodies and an easy-to use test strip. And while the initial usages will be to combat COVID-19, the technology has also been tested in the lab with extremely low concentrations of proteins secreted during myocardial infarcts (heart attacks) and to detect cerebrospinal fluid, indicating that this novel testing approach could be applied to a broad set of existing diagnostic. The unique test strips will be capable of molecular detection of antigen-antibody binding and can deliver qualitative and, in some cases, highly sensitive quantitative data.

The modular technology platform will be capable of testing for multiple infectious agents (viral, bacterial, and parasitic), disease-related proteins (cardiac disease and potentially cancer), and chemicals (substance abuse or environmental contaminants) within or external to the body using saliva, urine, blood, or other biological samples. This fundamental breakthrough in bioelectronic molecular testing is instant, reliable, inexpensive (pennies per strip), ultra-sensitive (ng/ml), highly specific, and portable. The product is not yet currently available for use in the US and is in the preparation phase of being submitted to the FDA for an EUA.

“What we are bringing to market is revolutionary. This device will be able to provide the fastest test not only for COVID-19, but also for a number of other viruses and specific disease states” said Blink Science CEO and president, Eric Doherty.

Related Links:
Blink Science, Inc.


Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
New
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.